WZ4002 ≥98%|CAS:1213269-23-8|5 mg|25 mg|100 mg

|WZ4002 inhibits EGFR in a variety of cell lines, including those harboring the T790M gatekeeper mutation. WZ2004 exhibits anticancer chemotherapeutic activity, inhibiting proliferation of lung adenocarcinoma cells and suppressing tumor growth in animal models.|C25H27ClN6O3|494.97|White Powder|-20°C|